Skip to main content
Log in

In vivo Model for the Evaluation of Molecules Active Towards Transmissible Spongiform Encephalopathies

  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  • Braida, D. Pozzi, M. and Sala, M., 2000. CP 55,940 protects against ischemia-induced electroencephalo-graphic flattening and hyperlocomotion in Mongolian gerbils. Neuroscience Letters, 296( 2–3), 69–72

    PubMed  Google Scholar 

  • Brown P., 2002. Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology. 58(12), 1720–1725

    PubMed  Google Scholar 

  • Cuajungco, M.P., Faget, K.Y., Huang, X., Tanzi, R.E. and Bush, A.I., 2000. Metal chelation as a potential therapy for Alzheimer's disease. Annals of the New York Academy of Sciences, 920, 292–304

    PubMed  Google Scholar 

  • Melov S., 2002}, ‘... and C is for Clioquinol’–the AbetaCs of Alzheimer's disease. Trends in Neurosciences, 25(3), 121–123

  • Sala, M., Leone, M.P., Lampugnani, P., Matturri, L. and Gori, E., 1997. Polydeoxyribonucleotide (defibro-tide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil. European Journal of Pharmacology, 328(2–3), 143–152

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ponti, W., Sala, M., Pollera, C. et al. In vivo Model for the Evaluation of Molecules Active Towards Transmissible Spongiform Encephalopathies. Vet Res Commun 28 (Suppl 1), 307–310 (2004). https://doi.org/10.1023/B:VERC.0000045433.45346.1c

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:VERC.0000045433.45346.1c

Navigation